Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas. [electronic resource] by
- Patnaik, A
- Appleman, L J
- Tolcher, A W
- Papadopoulos, K P
- Beeram, M
- Rasco, D W
- Weiss, G J
- Sachdev, J C
- Chadha, M
- Fulk, M
- Ejadi, S
- Mountz, J M
- Lotze, M T
- Toledo, F G S
- Chu, E
- Jeffers, M
- Peña, C
- Xia, C
- Reif, S
- Genvresse, I
- Ramanathan, R K
Producer: 20171222
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|